1 Reason I'd Happily Buy Pfizer (PFE) Stock and Never Sell

robot
Abstract generation in progress

The author invested in Pfizer (PFE) and finds its high dividend yield of 6.4% to be a primary reason to hold the stock long-term. Despite recent struggles and patent expirations for some drugs, Pfizer has an extensive pipeline of new drugs, including 32 in late-stage development, and is investing in a GLP-1 drug. The company’s valuation is currently attractive, making it a good option for long-term investors focused on dividend income.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin